Advertisement

Topics

Companies Related to "Effects of a CRF1 Receptor Antagonist on Human Startle in Normal Female Volunteers" [Most Relevant Company Matches] - Page: 20 RSS

22:52 EDT 21st March 2019 | BioPortfolio

Here are the most relevant search results for "Effects of a CRF1 Receptor Antagonist on Human Startle in Normal Female Volunteers" found in our extensive corporate database of over 50,000 company records.

Showing "Effects CRF1 Receptor Antagonist Human Startle Normal Female" Companies 476–500 of 2,600+

Probably Relevant

Bio-options, Inc

provides services and biological human materials to biotech and pharmaceutical companies to support their basic research. Our biological materials are obtained through collaborations with hospitals, pathologists and other physician specialists.Bio-options has a large repository of human tissue samples, along with serum and plasma of the major diseases, with a focus on the common tumors of the bre...


Microchips Biotech, Inc.

Microchips Biotech, Inc. is dedicated to improving the lives of patients by revolutionizing drug delivery. The company’s proprietary platform technology is a microchip-based implant which can store and release precise doses of drugs at scheduled intervals for up to 16 years. The microchip-based implant has the potential to address significant unmet ne...

Kenta Biotech

Kenta Biotech is pioneering the research and development of fully human IgM antibodies that are desperately needed for the treatment of severe hospital-acquired infections. Antibodies generated from Kenta's proprietary MabIgX® technology effectively target bacteria independently of resistance to antimicrobial agents. Furthermore, the MabIgX® technolo...


The Haworth Press Inc.

The Haworth Press, Inc., was officially incorporated in 1978 by Mr. Bill Cohen and Mr. Patrick McLoughlin. At that time, Bill was Director of Marketing at Human Sciences Press, Inc. (now owned by Plenum Press), and Patrick was President of Human Sciences Press, Inc

Ritter Pharmaceuticals, Inc.

Ritter Pharmaceuticals, Inc. develops novel therapeutic products that modulate the human gut microbiome to treat inflammatory, gastrointestinal and metabolic diseases. Ritter is advancing human gut health research by exploring the metabolic capacity of gut microbiota and translating the functionality of these microbiome modulators into safe and effectiv...

The Grubb Institute

The Grubb Institute was set up in 1969 to contribute to the well being and wholeness of society by enabling persons, communities and institutions to transform to meet real human need.Using expertise developed from the human sciences and applied Christian theology, we provide consultancy and action research to education, health, social care, religious and voluntary organisations, and business.Throu...

Sophiris Bio Inc.

Sophiris Bio Inc. is a biopharmaceutical company developing a clinical-stage, targeted treatment for the symptoms of benign prostatic hyperplasia (BPH or enlarged prostate), which it believes is an unsatisfied market with significant market potential. Sophiris’ lead candidate for BPH, PRX302, is designed to be as efficacious as pharmaceuticals, less i...

BioSante Pharmaceuticals, Inc. and ANI Pharmaceuticals, Inc.

BioSante’s corporate strategy is to develop high value medically-needed pharmaceutical products and to implement strategic alternatives with respect to its products and its company, including licenses, business collaborations and other business combinations or transactions with other pharmaceutical and biotechnology companies. BioSante’s products ...

Hesperos, Inc.

Hesperos, Inc, is a leader in efforts to characterize an individual’s biology with human-on-a-chip microfluidic systems. Founders Michael L. Shuler and James J. Hickman have been at the forefront of every major scientific discovery in this realm, from individual organ-on-a-chip constructs to fully functional, interconnected multi-organ systems. With a...

Scion Pharmaceuticals

Scion is focused on identifying and optimizing small-molecule drugs for the treatment of central nervous system (CNS) disorders and cardiovascular diseases. Scion's automated electrophysiology technology platform -- High-Throughput ElectroPhysiology, or HTEP -- permits the rapid discovery of small molecule drugs that modulate ion channels and receptors. Using HTEP assay technology, Scion can rapid...

Aastrom Biosciences Incorporated

Aastrom Biosciences, Inc. (Nasdaq: ASTM) is developing automated cell therapy systems designed to enable on-site cell production for therapeutic procedures using living cells in patients treated for cancer and other diseases and cells used in the restoration of normal tissues. The Company has received approval to affix the CE Mark to the various components of the AastromReplicell™ System, the SC...

Biomoda

Biomoda, Inc. is a developmental stage company engaged in the business of developing biopharmaceutical technology to diagnose and treat human diseases. The Company currently licenses two patents in the U.S. On November 10, 1992, the Company licensed a patent for the detection of cancers of the lung. A second patent, dealing with treatment of cancers of the lung, was licensed on February 21, 1995...

Raptor Pharmaceutical

Raptor Pharmaceutical Inc. is the culmination of years of experience and research by a consortium of scientists, investors, and creative minds with one common goal, the development of novel protein therapeutics directed at unmet medical needs. Raptor was incorporated in the State of Delaware on September 8, 2005. On January 27, 2006, Raptor purchased intellectual property pertaining to the researc...

Unum Therapeutics

Unum Therapeutics uses proprietary T-cell engineering technology in combination with tumor-targeting antibodies to activate the body’s own immune system to fight cancer. Unum’s lead program, based on its Antibody-Coupled T-cell Receptor (ACTR) technology, is expected to enter Phase I clinical testing in the coming months to assess safety and effi...

ExtenZe

ExtenZe is the best selling male enhancement product sold worldwide. It is a proprietary blend of pharmaceutical grade substances to make a revolutionary product for men. Laboratory tested and with no harmful side effects, ExtenZe is the most advanced product of its kind and it can work for men of any age. With more than a billion tablets sold, ExtenZe is now available at Wal-Mart, Walgreens, CVS,...

ADMA Biologics, Inc.

ADMA is a clinical stage biotechnology company which focuses its efforts on the development and commercialization of human plasma and plasma-derived therapeutics. ADMA’s mission is to develop and commercialize plasma-derived, human immune globulins targeted at niche patient populations with unmet medical needs. In addition, ADMA operates ADMA BioCente...

Adeza

Adeza is a medical technology company located in Sunnyvale, California. Adeza’s products are recognized worldwide through both direct sales and distribution in over 20 countries. Adeza’s product focus is on proprietary tests and services for the diagnosis of pregnancy-related and female reproductive disorders including premature birth and infertility. In the U.S., preterm birth is the leading ...

Benitec Limited

Benitec Ltd. is a leading international biotechnology company listed on the Australian Stock Exchange. Benitec was founded in 1997 to commercialize research from Queensland's Department of Primary Industries (DPI).Benitec is one of the pioneers of RNA interference (RNAi) technology, which can be used to precisely destroy RNA viruses and silence the expression of defective genes. Benitec’s core p...

NeoPharm

NeoPharm is a pharmaceutical Company engaged in the research and development of drugs for the diagnosis and treatment of various forms of cancer. Presently the Company has several drugs which are in varying stages of development: BUdR(Broxuridine), liposome encapsulated doxorubicin ("LED"), liposome encapsulated paclitaxel ("LEP"), liposome encapsulated antisense oligodeoxynucleotide ("LE-AON" and...

Embria Health Sciences

Embria Health Sciences, www.embriahealth.com, combines science and nature to bring high-quality, research-based natural ingredients to the global human nutrition market. Embria’s flagship ingredient, EpiCor, is an all-natural product designed to modulate and balance the human immune system and is manufactured using a proprietary technology which produ...

Ventria Bioscience

Ventria Bioscience, headquartered in Sacramento, California, is uniquely positioned to become a scientific leader in the biopharmaceutical industry. We are dedicated to developing and producing innovative, high value products that enhance and save lives.We have achieved scientific excellence through internal research and development and collaborations with world-renowned biotech and industry leade...

Kolltan Pharmaceuticals, Inc.

Kolltan is a development-stage company advancing therapeutics that target well-defined and validated molecular mechanisms of disease in areas of critical clinical need. Kolltan is developing a new generation of monoclonal antibody oncology therapeutics based on recent, seminal discoveries made in the laboratory of Dr. Joseph Schlessinger, Chairman of the D...

BM-Science

BM-SCIENCE Brain & Mind Technologies Research Centre is a small but growing scientific research organization established in 2002. It provides a nexus between scientific research in neuroscience and society. Our core team of highly qualified professionals in the scientific community is extended through a network of specialists in the different sub-areas of expertise. Our two major focuses and orien...

Foundation for a Smoke-Free World, Inc.

The Foundation is an independent, private foundation formed and operated free from the control or influence of any third party.  Philip Morris International, S.A. has provided the initial funding to the Foundation.  The Foundation makes grants and supports medical, agricultural and scientific research to end smoking and its health effects, and ...

Gadeta

Founded in 2015, Gadeta has developed a technology platform based on combinatorial T Cell receptor exchange (CTE) to create optimized gamma delta (γδ) T-cell receptors (TCRs) with an enhanced anti-cancer reactivity. Gadeta’s new cell-based anti-cancer product called T Cells Engineered To Express A Defined Gamma Delta TCR (TEGs) has strong therap...


More From BioPortfolio on "Effects of a CRF1 Receptor Antagonist on Human Startle in Normal Female Volunteers"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks